TMCTX | VIMAX | TMCTX / VIMAX | |
Total Expense Ratio | 1.21 | 0.05 | 2,420% |
Annual Report Gross Expense Ratio | 1.24 | 0.05 | 2,480% |
Fund Existence | 19 years | 24 years | - |
Gain YTD | 1.880 | 8.313 | 23% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.47B | 197B | 3% |
Annual Yield % from dividends | 0.00 | 1.49 | - |
Returns for 1 year | 1.82 | 14.33 | 13% |
Returns for 3 years | 21.61 | 26.45 | 82% |
Returns for 5 years | 41.49 | 62.28 | 67% |
Returns for 10 years | 116.63 | 125.24 | 93% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSTKX | 20.13 | 0.09 | +0.45% |
Goldman Sachs International Eq Inc Inv | |||
FZANX | 50.30 | -0.10 | -0.20% |
Fidelity Advisor New Insights Z | |||
PTEZX | 23.87 | -0.06 | -0.25% |
PGIM Quant Solutions Large-Cap Cor Eq Z | |||
ICTEX | 16.74 | -0.08 | -0.48% |
ICON Health and Information Tech Instl | |||
ODMCX | 10.88 | -0.08 | -0.73% |
JPMorgan SMID Cap Equity C |